CervoMed Inc.
NASDAQ: CRVO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Nasdaq Capital Market
- Sector
- Industrials
- Industry
- Specialty Business Services
- CEO
- John J. Alam
- Employees
- 15
- Headquarters
- Boston, United States
- IPO year
- 2008
- Market cap
- $30.2M
- Website
- https://www.cervomed.com
Loading CRVO…
Loading profile data…Frequently asked questions about CRVO
What does CervoMed Inc. (CRVO) do?
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse...
Where does CRVO trade?
CervoMed Inc. (CRVO) trades on the Nasdaq Capital Market.
What sector is CRVO in?
CervoMed Inc. (CRVO) operates in the Industrials sector, specifically in the Specialty Business Services industry.
Who is the CEO of CervoMed Inc.?
John J. Alam is the chief executive officer of CervoMed Inc. (CRVO).
Where is CervoMed Inc. headquartered?
CervoMed Inc. is headquartered in United States.
Does CRVO pay a dividend?
CervoMed Inc. (CRVO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRVO go public?
CervoMed Inc. (CRVO) completed its initial public offering in 2008.